Latest AI and machine learning research in clinical trials for healthcare professionals.
Deep learning shows promise in structure-based drug discovery, yet challenges persist in generating pharmacologically plausible molecules with valid 3D conformation and decent binding mode in the pocket. We introduce SE3-BiLingoMol, an SE(3)-equivariant Transformer for pocket-based 3D molecule generation, addressing two key limitations of existing language-model approaches. First, it uses Geometri...
Ecosystems are rapidly degrading. Widely used approaches to monitor ecosystems to manage them effectively are both expensive and time consuming. The recent proliferation of publicly available imagery from satellites, Google Earth, and citizen-science platforms holds the promise to revolutionising ecological monitoring and optimising their efficiency. However, the potential of these platforms to de...
The overuse of antibiotics in both veterinary and human medicine has resulted in the emergence of antibiotic-resistant bacteria, prompting a search fo...
Premature termination codons (PTCs) are a major cause of genetic diseases, but the efficacy of therapeutic readthrough agents is highly context-depend...
Antibodies play a central role in neutralizing pathogens through direct interference with viral entry and recruitment of effector immune cells. Howeve...
In vivo genetic engineering of T cells could overcome the logistical, biological, and safety challenges of ex vivo modification, but effective and saf...
Immoral decisions, which engage both cognitive control and reward system, bring both cognitive and neural consequences. However, how dishonesty has an...
Theories of the neural mechanism underpinning rapid recognition debate whether it relies solely on a feedforward sweep through the ventral stream or i...
Antisense oligonucleotides (ASOs) are a powerful class of drugs with the potential to treat a wide range of human diseases. However, the prediction of...
Populations of neurons in motor cortex signal voluntary movement. Most classic neural encoding models and current brain-computer interface decoders as...
This study presents a comprehensive, modular framework for AI-driven drug discovery (DD) and clinical trial simulation, spanning from target identific...
Accurately estimating changes in binding free energy (ΔΔG) is essential for understanding protein-protein interactions (PPIs) and guiding rational pro...
Major depressive disorder (MDD), bipolar disorder (BP), and schizophrenia (SCZ) involve learning impairments with poorly understood mechanisms. Unders...
Ion channels are central to regulating neuronal communication, cardiac rhythm, and muscle contraction. Their modulation can induce therapeutic benefit...
We present an AI-assisted pipeline for disease-specific drug landscape analysis. Given a disease name, the system assembles a comprehensive, evidence-...
The cerebellum, long regarded as a motor structure, is increasingly recognized for its role in higher-order cognitive and socio-emotional functions. I...
Placebo analgesia is a well-established medical phenomenon with overlapping neural representations between humans and rodents, but the genetic contrib...
Metabolic dysfunction-associated steatotic liver disease (MASLD) is a highly prevalent condition characterized by fat build-up in the liver and ranges...
Formal theories of reinforcement learning (RL) prescribe a clearly defined function for dopamine, namely modulating learning via reward prediction err...
Small interfering RNA (siRNA) therapeutics have extraordinary potential for targeted gene silencing. They mediate post-transcriptional gene regulation...